RingCentral Q1 2026 slides: AI products drive growth, margins expand

RingCentral posted a Q1 FY2026 beat, with EPS of $1.20 vs. $1.17 expected and revenue of $644.2 million vs. $642.7 million consensus, while the stock rose 2.8% after hours to $47. Management also raised/affirmed strong full-year targets, including FY2026 revenue of $2.62-$2.64 billion, non-GAAP EPS of $4.85-$5.01, and free cash flow of $590-$605 million. AI product adoption accelerated sharply, with paid AI customers now above 10% of ARR and several new products showing triple-digit growth.

Analysis

RNG is transitioning from a “quality compounder” to a self-funded AI distribution story. The key second-order effect is that higher-ARPU AI attach is now reducing the company’s historical dependency on seat expansion, which should make revenue growth more resilient in a slower IT spend environment. The market is likely still underestimating how quickly the mix shift can translate into multiple expansion if AI products stay above 100% net retention and continue to pull through adjacent modules.

The more important implication for competitors is not just feature parity, but channel economics: RNG’s installed base and upstream call control position give it a cheaper path to monetize AI than point solutions or late-cycle CCaaS vendors. That makes smaller AI contact-center specialists vulnerable to bundling pressure, while larger infrastructure incumbents may see slower deal cycles as customers consolidate around a single workflow layer. In contrast, general-purpose collaboration names with weaker contact-center penetration may not see the same conversion from AI hype into monetizable ARR.

The main risk is that the stock is already discounting a lot of the margin inflection and balance-sheet repair; near-term upside likely requires either another quarter of AI acceleration or a step-up in guidance credibility. If AI attach stalls below the current pace, the market could quickly re-rate RNG back toward a “steady low-teens grower” multiple, especially given the recent run. A second-order downside is execution risk from elevated R&D: if new product spend does not convert into durable ARR over the next 2-3 quarters, operating leverage could look less repeatable than the headline margins suggest.

Contrarian view: consensus may be too focused on the earnings beat and not enough on durability of the growth rate. The real question is whether AI is additive demand or simply improving monetization of the same customer base; if it’s mostly the latter, the multiple should compress once the early-adopter phase normalizes. That said, the balance sheet improvement means downside is now more likely to come from de-rating than from fundamental stress.

Key Decisions for Investors

• Maintain a tactical long RNG into the next 1-2 quarters only if AI product metrics remain the primary KPI; target upside on multiple expansion, but trim into strength near prior highs as the stock is already pricing in good execution.
• Buy RNG calls or call spreads 2-4 months out to express upside from another AI-driven guidance raise; define risk tightly because the stock can de-rate quickly if AI attach decelerates.
• Pair trade: long RNG / short a slower-growing UCaaS or legacy collaboration peer over the next 1-2 quarters, on the thesis that AI monetization and balance-sheet repair will drive relative re-rating.
• Avoid chasing the move outright after the post-earnings pop; use pullbacks for entry and require evidence that paid AI customers continue to outgrow the core subscription base.
• For risk control, place a stop on any tactical long if management commentary shifts from monetization to experimentation, since that would suggest the AI flywheel is not yet converting into durable ARR.